Sunday, November 22, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Health

Genepeeks agrees to distribution with CORE

Fiinews by Fiinews
October 18, 2017
in Health, Investment, Manufacturing
Reading Time: 1 min read
A A
0
0
SHARES
11
VIEWS
LinkedinShare on Twitter

CORE joins global network

GenePeeks, Inc., a computational genomics company focused on transforming disease risk analysis, has announced an exclusive distribution agreement with CORE Diagnostics, a next-generation diagnostics provider committed to bringing best-in-class clinical technology and innovation to India.

This new distribution agreement furthers GenePeeks’ goal of expanding access to its breakthrough preconception screen and advanced analytics platform in new markets around the world.

CORE will exclusively offer GenePeeks’ preconception screen in their extensive market of twenty-nine states and seven union territories across India, greatly expanding GenePeeks global footprint.

“GenePeeks is delighted to add CORE Diagnostics to our list of outstanding global partners,” said Anne Morriss, Co-founder and Chief Executive Officer of GenePeeks.

“We look forward to working with the exceptional CORE team to address the European bias embedded in traditional screening and help Indian families better understand their risk of conceiving a child with a serious genetic disease,” said Morriss.

Zoya Brar, co-founder and managing director of CORE Diagnostics stated, “We are excited to partner with GenePeeks to expand our portfolio of innovative testing services and support the growing interest from Indian families and their healthcare providers in preconception screening. GenePeeks’ technology provides a unique opportunity to identify risk to Indian families that was often uncharacterized historically and hidden from clinical view.”

GenePeeks’ preconception screening technology uniquely integrates DNA information from two genetic participants to predict the potential genomes of a future child. fii-news.com

Tags: CORE DiagnosticsGenePeeks Inc
ShareTweetShare

Related Posts

PIB
Manufacturing

Manufacture: BRIC aims for $1trn bioeconomy by 2047

by Fiinews
November 22, 2026
0
15

Scientific achievements must translate into technologies, products and solutions, says Minister The integration of biotechnology research institutions under the Biotechnology...

PIB
Manufacturing

Manufacture: Paswan wants value in agriculture products

by Fiinews
November 22, 2026
0
17

Industry encouraged to develop healthier beverage alternatives, including millets and indigenous ingredients Minister of Food Processing Industries Chirag Paswan has...

PIB, IACC

Invest: US capital and Indian talent can transform economy

November 21, 2026
18
PM at FICCI AGM

Invest: PM applauds rating agencies take on economy

November 21, 2026
25
BRACCO

Invest: Italian companies keen on India

November 20, 2026
23
Perma Pipe

Invest: Perma-Pipe acquires 51% of Welspun unit

November 20, 2026
48
SBI YONO

Recent News

  • Tender: PM inaugurates projects in Vaishali
  • Manufacture: BRIC aims for $1trn bioeconomy by 2047
  • Export: Ministers review 6th round of CEPA in Delhi
  • Market: Greaves expands global marine business
  • Market: Polycab strengthens presence in US

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.